The occurrence frequency of prostate cancer in males with BRCA2 mutations is approximately 5 times higher than expected in the general population and the risk to develop pancreatic cancer in males and females with a BRCA2 mutation is 82.5 times higher and approximately 14 times higher, respectively [24]. This evidence concerns the gene BRCA2 and Familial prostate cancer.